Cricketer Shardul Thakur battled through an extremely high fever while playing his Ranji Trophy match in Lucknow but had to ...

The most common adverse events were pyrexia, headache and flushing. Farletuzumab in combination with platinum and taxane increased the objective response rate of patients with relapsed ovarian ...

Amgen has shared (PDF) the first phase 3 data on its $400 million eczema drug, linking the | Amgen has shared the first phase ...

Inc. (Nasdaq: TSVT) today announced that the Company, in partnership with study sponsor Bristol Myers Squibb (BMS), will ...

Amgen (AMGN) shares were down 5% Wednesday, the day after the company reported Phase 3 results for its drugs rocatinlimab and ...

The Regional Veterinary Laboratories (RVLs) have detected Schmallenberg virus (SBV) in reports of milk drop syndrome in dairy ...

Amgen (NASDAQ:AMGN) shares were down 5% Wednesday, the day after the company reported Phase 3 results for its drugs ...

The most common AEs included diarrhea, cancer progression, anemia, hypokalemia, nausea, vomiting, and pyrexia, with placebo-treated patients reporting higher rates of diarrhea, nausea, and vomiting.

Let’s face it: reading medical studies from the National Bureau of Economic Research (NBER) is about as thrilling as watching ...

AEs included “reduced appetite, diarrhea, pyrexia, weariness, upper respiratory tract infection, lethargy, somnolence and bronchitis.” We also have Eisai’s Lorcaserin, which has been tested ...

of any grade in ≥7.5% of patients were nausea (18.9%), fatigue (18.9%), anemia (17.0%), abdominal pain (15.1%), constipation (13.2%), vomiting (13.2%), diarrhea (11.3%), pyrexia (9.4%), weight ...